Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid-refractory Acute Graft-versus-Host Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05333029
What this trial is testing

Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD

Who this might be right for
Graft Versus Host Disease
Molly Gallogly
Testing effectiveness (Phase 2)Active Not RecruitingNCT06075706
What this trial is testing

Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid-refractory Acute Graft-versus-host Disease
medac GmbH 49
Not applicableUnknownNCT04622475
What this trial is testing

Efficacy and Safety of FMT Capsule Treating Steroid-refractory GI-aGvHD

Who this might be right for
Steroid-refractory Gastrointestinal Acute Graft Versus Host Disease
Nanfang Hospital, Southern Medical University 10
Not applicableAvailableNCT05047328
What this trial is testing

Early Access Program With Inolimomab in Steroid-refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid Resistant Acute Graft Versus Host Disease
ElsaLys Biotech
Testing effectiveness (Phase 2)Study completedNCT00492921
What this trial is testing

High-Dose Cyclophosphamide for Steroid Refractory GVHD

Who this might be right for
Graft Versus Host Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Testing effectiveness (Phase 2)Ended earlyNCT01475162
What this trial is testing

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Medical College of Wisconsin 14
Early research (Phase 1)WithdrawnNCT05443464
What this trial is testing

Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)

Who this might be right for
GVHD,Acute
Ossium Health, Inc.
Not applicableLooking for participantsNCT06321198
What this trial is testing

A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

Who this might be right for
Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)
Anhui Provincial Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT02396628
What this trial is testing

Ruxolitinib In GvHD

Who this might be right for
Graft vs Host Disease
Prof. Dr. Nikolas von Bubnoff 22
Large-scale testing (Phase 3)Ended earlyNCT04128319
What this trial is testing

T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802)

Who this might be right for
Steroid-Refractory Acute Graft Versus Host Disease
Xenikos 3
Early research (Phase 1)Looking for participantsNCT06750133
What this trial is testing

Universal CNK-UT Therapy for Refractory aGVHD

Who this might be right for
Acute Graft-versus-Host Disease
First Affiliated Hospital of Zhejiang University 23
Testing effectiveness (Phase 2)Study completedNCT03459040
What this trial is testing

A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD

Who this might be right for
Graft-versus-host-diseaseGVHD
John Levine 30
Testing effectiveness (Phase 2)Ended earlyNCT04910152
What this trial is testing

Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD

Who this might be right for
Acute Graft Versus Host DiseaseSteroid Refractory Graft Versus Host Disease
Hannah Choe, MD 2
Testing effectiveness (Phase 2)Ended earlyNCT05415410
What this trial is testing

Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD)

Who this might be right for
GVHD
VectivBio AG 31
Not applicableStudy completedNCT04342442
What this trial is testing

Identification of Novel Targetable Kinases in SR-a GvHD

Who this might be right for
Graft Versus Host Disease
University of Freiburg 24
Testing effectiveness (Phase 2)Study completedNCT02953678
What this trial is testing

Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 71
Large-scale testing (Phase 3)Active Not RecruitingNCT04769895
What this trial is testing

MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients

Who this might be right for
Acute Graft Versus Host Disease in IntestineSteroid Refractory GVHD
MaaT Pharma 66
Testing effectiveness (Phase 2)Study completedNCT00408928
What this trial is testing

Study on the Safety and Effectiveness of VELCADE® in the Treatment of Graft-Versus-Host Disease

Who this might be right for
Graft-versus-Host Disease
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 11
Not applicableApproved For MarketingNCT03147742
What this trial is testing

An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation
Testing effectiveness (Phase 2)Ended earlyNCT01485055
What this trial is testing

Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease

Who this might be right for
Graft Versus Host DiseaseSteroid Refractory GVHDAcute GVH Disease
Nationwide Children's Hospital 11
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation